Steven J. Burton
President at ProMetic BioSciences Ltd.
Profile
Steven J.
Burton is currently the President & Chief Scientific Officer at Astrea Bioseparations Ltd.
and the President at ProMetic BioSciences Ltd.
He previously served as the Chief Executive Officer at Liminal BioSciences, Inc.
Steven J. Burton active positions
Companies | Position | Start |
---|---|---|
ProMetic BioSciences Ltd.
ProMetic BioSciences Ltd. Miscellaneous Commercial ServicesCommercial Services ProMetic BioSciences Ltd. operates as a biopharmaceutical company. The company was founded by Christopher Robin Low and is headquartered in Laval, Canada. | President | - |
Astrea Bioseparations Ltd.
Astrea Bioseparations Ltd. Medical SpecialtiesHealth Technology Astrea Bioseparations Ltd. develops and manufactures affinity purification technology. It specializes in affinity chromatography and bioseparations, specifically purification of proteins and the elimination of contaminants including pathogens. The company was founded in 1987 and is headquartered in Cambridge, the United Kingdom. | President | 2021-06-13 |
Former positions of Steven J. Burton
Companies | Position | End |
---|---|---|
LIMINAL BIOSCIENCES INC. | President | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
LIMINAL BIOSCIENCES INC. | Health Technology |
Private companies | 2 |
---|---|
ProMetic BioSciences Ltd.
ProMetic BioSciences Ltd. Miscellaneous Commercial ServicesCommercial Services ProMetic BioSciences Ltd. operates as a biopharmaceutical company. The company was founded by Christopher Robin Low and is headquartered in Laval, Canada. | Commercial Services |
Astrea Bioseparations Ltd.
Astrea Bioseparations Ltd. Medical SpecialtiesHealth Technology Astrea Bioseparations Ltd. develops and manufactures affinity purification technology. It specializes in affinity chromatography and bioseparations, specifically purification of proteins and the elimination of contaminants including pathogens. The company was founded in 1987 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Steven J. Burton